American Association for the Advancement of Science, Science Translational Medicine, 120(4), 2012
DOI: 10.1126/scitranslmed.3003728
Full text: Unavailable
Two recent studies offer insights on how cancer cells develop resistance to targeted therapies and possible ways to battle this therapeutic bottleneck.